|Articles|March 2, 2017

Pharmaceutical Technology

  • Pharmaceutical Technology-03-02-2017
  • Volume 41
  • Issue 3

Tabletop Pill Counter Automatically Counts and Fills Solid Oral-Dose Products

The Pharmafill TC4 Tabletop electronic tablet counter from Deitz Co. automatically counts pills, tablets, capsules, softgels, caplets, lozenges, and other solid oral-dose products and fills them into bottles.

The Pharmafill TC4 Tabletop electronic tablet counter from Deitz Co. automatically counts pills, tablets, capsules, softgels, caplets, lozenges, and other solid oral-dose products and fills them into bottles. The Pharmafill TC4 counts translucent, transparent, and opaque solid oral-dose products at up to 2000 per minute. The Tabletop TC4 is a computer-controlled operation, and measures 34 inches across, 21 inches deep, and 30 inches in height. The TC4 entry level counter includes an air guide system that automatically separates and aligns the pills on a single layer, a vibratory hopper feeder that automatically regulates the flow of tablets into the counter, and an optional smart bottle sensing system that automatically stops operation in the event of a problem with the bottle.

Deitz


Related to this article

Are Your Supplier Selection and Oversight Processes Robust Enough?
Despite best efforts to ensure a contract organization is following GMPs, a warning letter is issued by the FDA. Susan J. Schniepp, distinguished fellow at Nelson Labs, and Siegfried Schmitt, PhD, vice president, Technical at Parexel, provide advice for create a robust supplier selection and oversight system.
white pill capsule isolated on white background | Image Credit: ©F16-ISO100 -stock.adobe.com
PharmTech spoke with Chiara Bergerone, deputy CEO of Roquette’s Health & Pharma Solutions Business, about the company’s hydroxypropyl methylcellulose (HPMC) capsule, which was previewed at CPHI Milan 2026 in October.
Transitioning mRNA from R&D to GMP
Marco Pupo, PhD, innovation and development coordinator at Anemocyte, discusses the R&D-to-GMP transition and the changing shape of mRNA manufacturing facilities.